Caroline E McNeil

Learn More
If you ask public relations departments, the answer is simple. Press releases from the University of Rochester in New York, Georgetown University in Washington, D.C., and Queensland University in Brisbane, Australia, have claimed responsibility for original work leading to the Merck or GlaxoSmithKline vaccine. The two vaccines are nearly identical, based on(More)
L ast month, an expert panel said that patients with advanced colorectal cancer should not be treated with cetuximab or panitumumab if their tumors have mutations in the K-Ras oncogene. The major new recommendation from the National Comprehensive Cancer Network (NCCN), based on a consensus of experts at 21 comprehensive cancer centers across the United(More)
O n Jan. 1, the University of Minnesota launched a major overhaul of its institutional review boards (IRBs) with the goal of increasing efficiency, quality, and — most importantly for many IRB critics — the speed with which it reviews new clinical trial protocols. The reforms represent one approach to fi xing the problems that have been plaguing IRBs(More)
magnitude of the decline is certainly persuasive, said lead author Donald Berry, Ph.D., who heads the division of quantitative sciences at M. D. Anderson. “It’s huge, and that’s the most compelling thing,” he said. The month-by-month data, in particular, are startling, Berry said. From July 2002 to December 2003, breast cancer rates fell an average of 1% a(More)